Novavax Files for Interim Authorization of COVID-19 Vaccine in Singapore

(Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced its submission to the Singapore Health …
( read original story …)

---

Search your Hotel